(Q39847614)

15 September 2017

1 reference

title

Mechanisms of cross-species activity of mammalian interferons (English)

1 reference

15 September 2017

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

19 April 2023

author name string

W. A. Carter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A392554

19 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=392554

19 April 2023

publication date

1 January 1979

1 reference

full work available at URL

15 September 2017

https://api.elsevier.com/content/article/PII:0163725879900317?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

https://api.elsevier.com/content/article/PII:0163725879900317?httpAccept=text/plain

19 April 2023

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Pharmacology & Therapeutics

19 April 2023

published in

1 reference

15 September 2017

volume

7

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

245-252

1 reference

Oligonucleotide inhibitor of protein synthesis made in extracts of interferon-treated chick embryo cells: Comparison with the mouse low molecular weight inhibitor

15 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Hormone and anti-hormone action at the target cell

19 April 2023

3

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Porcine leukocyte interferon and antiviral activity in human cells

19 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Molecular size heterogeneity of human leukocyte interferon

19 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Rapid purification of biologically active individual histone messenger RNAs by hybridization to cloned DNA linked to cellulose

19 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Binding of human fibroblast interferon to concanavalin A-agarose. Involvement of carbohydrate recognition and hydrophobic interaction

19 April 2023

9

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Mapping of the residues responsible for the negative cooperativity of the receptor-binding region of insulin

19 April 2023

10

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Pronounced antiviral activity of human interferon on bovine and porcine cells

19 April 2023

11

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Effect of tunicamycin on IgM, IgA, and IgG secretion by mouse plasmacytoma cells

19 April 2023

14

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Virus interference. I. The interferon

19 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Molecular structure of human fibroblast and leukocyte interferons: probe by lectin and hydrophobic chromatography

19 April 2023

17

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Recognition of IgG by Fc receptor and complement: Effects of glycosidase digestion

19 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Comparative aspects of glycoprotein structure

19 April 2023

21

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma

19 April 2023

23

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Differences in sialic acid content of human interferons

19 April 2023

26

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Human interferons: characterization of the major molecular components

19 April 2023

27

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Cell-free synthesis of human interferon

19 April 2023

28

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Receptor-binding region of insulin

19 April 2023

29

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Proposal for a common oligosaccharide intermediate in the synthesis of membrane glycoproteins

19 April 2023

30

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Human leukocyte interferon purified to homogeneity

19 April 2023

31

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Human leukocyte interferon: production, purification to homogeneity, and initial characterization

19 April 2023

32

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Interference of nucleoside diphosphate derivatives of 2-deoxy-D-glucose with the glycosylation of virus-specific glycoproteins in vivo

19 April 2023

33

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Immediate glycosylation of Sindbis virus membrane proteins

19 April 2023

34

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Interferons: Anti-neoplastic drugs?

19 April 2023

35

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Structural elucidation of tunicamycin. II. The structure of tunicamycin.

19 April 2023

37

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

19 April 2023

Interferons

38

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

Hazards of human leukocyte interferon therapy

19 April 2023

40

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90031-7

19 April 2023

Identifiers

1 reference

15 September 2017

1 reference